
Understanding and Managing ATTR Amyloidosis: From Epidemiology to Emerging Therapies

Understanding and Managing ATTR Amyloidosis: From Epidemiology to Emerging Therapies is organized by Projects In Knowledge Inc. (PIK).
Release Date: May 10, 2023
Termination Date: May 09, 2024
Activity Goal:
The goal of this activity series is to provide expert commentary and analysis on current and emerging management strategies in ATTR amyloidosis.
Learning Objective(s):
• Recognize symptom constellations indicative of transthyretin amyloidosis (ATTR) and engage in appropriate investigatory testing to confirm or exclude this diagnosis.
• Utilize approved and emerging agents, if and when they become available, to delay ATTR amyloidosis disease progression and improve patient outcomes.
Additional details will be posted as soon as information is available.